Globus Medical Net Worth
Globus Medical Net Worth Breakdown | GMED |
Globus Medical Net Worth Analysis
Globus Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Globus Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Globus Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Globus Medical's net worth analysis. One common approach is to calculate Globus Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Globus Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Globus Medical's net worth. This approach calculates the present value of Globus Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Globus Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Globus Medical's net worth. This involves comparing Globus Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Globus Medical's net worth relative to its peers.
To determine if Globus Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Globus Medical's net worth research are outlined below:
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: GCL bernimmt Magusa Global Cargo fr weitere Expansion im lateinamerikanischen Show-Business-Markt |
Globus Medical Quarterly Good Will |
|
Globus Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Globus Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Globus Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Globus Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Globus Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Globus Medical backward and forwards among themselves. Globus Medical's institutional investor refers to the entity that pools money to purchase Globus Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.9 M | Norges Bank | 2024-06-30 | 1.8 M | Champlain Investment Partners, Llc | 2024-09-30 | 1.8 M | Gw&k Investment Management, Llc | 2024-09-30 | 1.8 M | Geneva Capital Management | 2024-09-30 | 1.6 M | Citadel Advisors Llc | 2024-09-30 | 1.6 M | William Blair Investment Management, Llc | 2024-09-30 | 1.6 M | Axa Sa | 2024-09-30 | 1.5 M | Van Berkom And Associates Inc | 2024-09-30 | 1.5 M | Vanguard Group Inc | 2024-09-30 | 10.6 M | Blackrock Inc | 2024-06-30 | 10.3 M |
Follow Globus Medical's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 11.59 B.Market Cap |
|
Project Globus Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.04 | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.03 | 0.03 |
When accessing Globus Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Globus Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Globus Medical's profitability and make more informed investment decisions.
Please note, the presentation of Globus Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Globus Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Globus Medical's management manipulating its earnings.
Evaluate Globus Medical's management efficiency
Globus Medical has return on total asset (ROA) of 0.0473 % which means that it generated a profit of $0.0473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0222 %, meaning that it created $0.0222 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of December 4, 2024, Return On Tangible Assets is expected to decline to 0.04. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Globus Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 82.5 M, whereas Return On Tangible Assets are forecasted to decline to 0.04.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 35.35 | 37.12 | |
| Tangible Book Value Per Share | 14.49 | 15.22 | |
| Enterprise Value Over EBITDA | 19.60 | 13.63 | |
| Price Book Value Ratio | 1.51 | 1.43 | |
| Enterprise Value Multiple | 19.60 | 13.63 | |
| Price Fair Value | 1.51 | 1.43 |
Globus Medical benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue 4.5446 | Revenue 2.5 B | Quarterly Revenue Growth 0.631 | Revenue Per Share 18.217 | Return On Equity 0.0222 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Globus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kelly Huller over two months ago Acquisition by Kelly Huller of 40000 shares of Globus Medical at 53.75 subject to Rule 16b-3 | ||
Daniel Scavilla over three months ago Acquisition by Daniel Scavilla of 60000 shares of Globus Medical subject to Rule 16b-3 | ||
James Tobin over six months ago Acquisition by James Tobin of 15000 shares of Globus Medical subject to Rule 16b-3 | ||
Wolterman Dan over a year ago Acquisition by Wolterman Dan of 24025 shares of Globus Medical subject to Rule 16b-3 | ||
James Tobin over a year ago Acquisition by James Tobin of 15000 shares of Globus Medical subject to Rule 16b-3 |
Globus Medical Corporate Filings
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 5th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 31st of May 2024 Other Reports | ViewVerify |
Globus Medical Earnings per Share Projection vs Actual
Globus Medical Corporate Directors
| Steve Zarrilli | Independent Director | Profile | |
| Ann Rhoads | Independent Director | Profile | |
| James Tobin | Independent Director | Profile | |
| Daniel Lemaitre | Independent Director | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 42.231 | Earnings Share 0.62 | Revenue Per Share 18.217 | Quarterly Revenue Growth 0.631 | Return On Assets 0.0473 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.